Literature DB >> 11457470

Variability in platelet responses to collagen--comparison between whole blood perfusions, traditional platelet function tests and PFA-100.

A Lepäntalo1, J H Beer, P Siljander, M Syrjälä, R Lassila.   

Abstract

The purpose of this study was to determine if the results obtained in platelet function tests and whole blood perfusions are associated with those in platelet function analyser (PFA)-100. We used collagen type I monomers and fibrils to analyse the distinct roles of glycoprotein (GP) Ia/IIa and other collagen receptors in flowing blood under a high shear rate (1600/s) and in aggregation studies. Also, anticoagulation [citrate vs. D-phenylalanyl-1-prolyl-1 arginine chloromethyl ketone (PPACK)] was varied to enhance the functions of GP Ia/IIa, since it has been shown that the cation-poor environment of citrated blood impairs GP Ia/IIa-dependent platelet recruitment. Large interindividual variability (45-fold) was detected in deposition of platelets in whole blood perfusions over collagen monomers, whereas this variation was only fourfold in fibrils. In PFA, this variation was reduced to 2.5-fold. However, platelet deposition on monomers is associated with epinephrine-enhanced PFA (r=-.49, P<.03), whereas platelet deposition on fibrils is correlated with adenosine diphosphate (ADP)-enhanced PFA (r=-.47, P<.05), suggesting a distinct synergism between epinephrine and monomers (GP Ia/IIa) as well as ADP with fibrils (other collagen receptors). Donors with 807 C/C polymorphism of GP Ia (n=14) had longer lag phase in aggregation experiments compared with C/T (n=7) both by monomers and fibrils (P<.04), but these polymorphisms with their mild impact on GP Ia/IIa activity did not markedly differ in other tests. In conclusion, the results obtained in perfusion studies and PFA experiments correlated, but PFA fails to reveal the large-scale variability related to collagen-induced platelet responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11457470     DOI: 10.1016/s0049-3848(01)00283-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

Review 1.  Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

Authors:  Diana A Gorog; Joseph M Sweeny; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04-14       Impact factor: 32.419

2.  Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes.

Authors:  Markus Schmugge; Oliver Speer; Sabine Kroiss; Walter Knirsch; Oliver Kretschmar; Margaret L Rand; Manuela Albisetti
Journal:  Eur J Pediatr       Date:  2015-01-16       Impact factor: 3.183

3.  Shear-induced platelet aggregation: 3D-grayscale microfluidics for repeatable and localized occlusive thrombosis.

Authors:  Michael T Griffin; Dongjune Kim; David N Ku
Journal:  Biomicrofluidics       Date:  2019-10-01       Impact factor: 2.800

4.  Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate.

Authors:  Dina S Vara; Michelangelo Campanella; Ilaria Canobbio; Warwick B Dunn; Giuseppe Pizzorno; Michio Hirano; Giordano Pula
Journal:  Thromb Haemost       Date:  2013-03-14       Impact factor: 5.249

5.  Plasma salicylate level and aspirin resistance in survivors of myocardial infarction.

Authors:  Nabeel Ahmed; John Meek; Graham J Davies
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.